New clinical study: Chr. Hansen probiotics strengthen the body's immune system

07-09-2011
A new clinical study published in the acknowledged British Journal of Nutrition documents that either one of Chr. Hansen’s probiotic bacteria strains BB-12® or L. casei 431® is an effective means to support the immune system. The key findings of the study indicate that daily consumption of at least one billion colony forming units of BB-12® or L. casei 431® may strengthen the immune system’s defense against common infections such as flu and colds.

The randomized, double-blind, placebo-controlled study was conducted in cooperation with the Luigi Sacco Hospital in Milan, Italy and the University of Milan. ”This new clinical study is part of Chr. Hansen’s comprehensive clinical study program,” says Chr. Hansen’s Birgit Michelsen, Director of Scientific Affairs, Health & Nutrition Division. “The outcomes of this study, as well as data from previous studies on BB-12® and L. casei 431®, show that supplementation with these probiotic strains result in a strengthening of various parts of the immune system. This will very likely translate into a clinical benefit, such as reduced rates of infection”.

 

In the study, 211 healthy adults were divided into two probiotic groups (receiving BB-12® and L. casei 431®, respectively) and two placebo groups. The number of persons experiencing a substantial increase in flu antibodies was significantly greater in both probiotic groups than in the placebo groups. For example, in the BB-12® group 66% had a substantial increase in the specific antibody 'IgG3' compared to only 4% in the placebo group. Likewise, in the L. casei 431® group 46% had a substantial increase compared to just 2% in the placebo group.

 

“Food manufacturers as well as dietary supplements producers observe an increasing consumer interest in probiotics with credible, scientifically documented health benefits,” comments Lars Bredmose, Marketing Director, Probiotic Cultures, Chr. Hansen. “This study further strengthens Chr. Hansen’s probiotic portfolio of strains with documented health benefits”.

 

Lars Bredmose continues: “We are already successfully marketing powerful food and dietary supplements solutions, which contain BB-12® and L. casei 431®, for consumer products supporting the immune system: probiotic yoghurt blends, chewable tablets, powder sticks, and capsules. We expect this study to further inspire international players in the food and supplements industries to launch probiotic products with evident health benefits.”

 

 

Read the study article called “Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model; a randomised, double-blind, placebo-controlled study” here:http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=8369014

 

 

www.chr-hansen.com/probiotics

 

 

For further information on this press release, please contact:

 

Ulrik Raabjerg Soendergaard, Communications Consultant, Corporate Communications

Telephone: +45 45 74 71 09

E-mail: dkurs@chr-hansen.com

 

 

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food,

nutritional, pharmaceutical and agricultural industries. All solutions are based on strong research and

development competencies and significant technology investments. Revenue in FY2009/10 was EUR 576

million. The company enjoys market leadership in all its divisions: Cultures & Enzymes, Health & Nutrition

and Natural Colors. There are more than 2,300 dedicated employees in over 30 countries. Chr. Hansen is

listed on the NASDAQ OMX stock exchange in <place w:st="on"><city w:st="on">Copenhagen</city>, <country-region w:st="on">Denmark</country-region></place>. For further information, please visit www.chr-hansen.com.

 

 

Related news:
For further information please contact:
Ulrik Raabjerg Søndergaard
Communications Consultant

About us

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2012/13 financial year was EUR 738 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Related news

New study: Probiotics may help you fight off the flu
28-10-2010
New study: Probiotics may help you fight off the flu
A new clinical study sponsored by Chr. Hansen and conducted in cooperation with a hospital and the University of Milan documents that supplementation with either of the strains BB-12® or L. casei 431® may improve the body’s resistance to common infections such as flu and colds.

Contact our press team

Eva Veileborg Hald
Director
Denmark, Hoersholm, headquarters
Corporate Communications
Phone:+45 30 60 45 26
Send e-mail
Ulrik Raabjerg Søndergaard
Communications Consultant
Denmark, Hoersholm, headquarters
Corporate Communications
Phone:+45 45 74 71 09
Mobile: +45 30 38 28 74
Send e-mail
Helle Rexen
Communications Consultant
Denmark, Hoersholm, headquarters
Corporate Communications
Phone:+45 45 74 76 36
Mobile: +45 2074 2840
Send e-mail

Subscribe to our mail service
And get the latest press releases delivered by email.

Follow Chr. Hansen on Twitter
for the latest press releases, company announcements and job announcements

Follow our news feeds
We also provide a news feed you can subscribe to via RSS

Latest news

22-10-2014
Annual results: 8% organic growth
After solid growth in the fourth quarter Chr. Hansen...
14-10-2014
71% of U.S. moms agree: Food and happiness go hand in hand
Thought for Food survey identifies trends in food purchasing
07-10-2014
Chr. Hansen launches new preservatives-free animal rennet range
- allowing traditional cheese production to match modern...
More news